Sriram Ryali, CFO at Eiger Biopharmaceuticals, holds 17.36K shares in Caribou Biosciences (Ticker: CRBU), holds 175.79K shares in Codexis (Ticker: CDXS), holds 41.57K shares in Eiger Biopharmaceuticals (Ticker: EIGRQ). Most recently, Sriram Ryali Bought ― shares of Caribou Biosciences on Jan 30, 2025 for an estimated value of 24.65K.
What is the percentage of profitable transactions made by Sriram Ryali?
The percentage of profitable transactions made by Sriram Ryali is 75%.
What is the average return per transaction made by Sriram Ryali?
The average return per transaction made by Sriram Ryali is 26.20%.
What stocks does Sriram Ryali hold?
Sriram Ryali holds: EIGRQ, CDXS, CRBU stocks.
What was Sriram Ryali’s latest transaction?
Sriram Ryali latest transaction was an Informative Buy of $24.65K.
What was Sriram Ryali's most profitable transaction?
Sriram Ryali’s most profitable transaction was an Informative Sell of EIGRQ stock on March 14, 2022. The return on the trade was 77.70%.
What is Sriram Ryali's role in Eiger Biopharmaceuticals?
Sriram Ryali's role in Eiger Biopharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.